Citations

Clear

6273 citation(s) found for "To, Andrew".

Diagnosis, assessment, and management of surgical complications following esophagectomy
Grimminger, Peter , Bergeat, Damien , Bertheuil, Nicolas , Chandramohan, Servarayan Murugesan, Chen, Ke‐Neng , Chon, Seung‐Hun , Collet, Denis, Goh, Khean‐Lee, Gronnier, Caroline , Liu, J F, Nafteux, P., Pirchi, Enrique D, Schiesser, Marc , Wu, Aaron , Wu, Peter , Buttar, Navtej , Chang, Andrew C. , Grimminger, Peter P , Chang, Andrew C , Goense, Lucas , Gockel, Ines , Meunier, Bernard , Thieme, René

Mayo Clinic

Annals of the New York Academy of Sciences | July 9, 2018 | Volume: 1434 | Issue: 1 | Pages: 254-273

10.1111/nyas.13920 | PMID 29984413 Get It

AbstractDespite improvements in operative strategies for esophageal resection, anastomotic leaks, fistula, postoperative pulmonary complications, and chylothorax can occur. Our review seeks to identify potential risk factors, modalities for early diagnosis, and novel interventions that may ameliorate the potential adverse effects of these surgical complications following esophagectomy.
Sex‐related differences in the prevalence of cognitive impairment among overweight and obese adults with type 2 diabetes
Carmichael, Owen , Yaşar, Sevil , Hugenschmidt, Christina E. , Hazzard, William R., Hayden, Kathleen M. , Rapp, Stephen R. , Johnson, Karen , Hoscheidt, Siobhan M. , Mielke, Michelle M. , Mielke, Michelle M , Espeland, Mark Andrew , Neiberg, Rebecca H.

Mayo Clinic

Alzheimer's & Dementia | July 4, 2018 | Volume: 14 | Issue: 9 | Pages: 1184-1192

10.1016/j.jalz.2018.05.015 | PMID 30201101 Get It

AbstractIntroductionType 2 diabetes mellitus and obesity may increase risks for cognitive decline as individuals age. It is unknown whether this results in different prevalences of cognitive impairment for women and men.MethodsThe Action for Health in Diabetes, a randomized controlled clinical trial of a 10‐year intensive lifestyle intervention, adjudicated cases of cross‐sectional cognitive impairment (mild cognitive impairment or dementia) 10–13 years after enrollment in 3802 individuals (61% women).ResultsThe cross‐sectional prevalences of cognitive impairment were 8.3% (women) and 14.8% (men): adjusted odds ratio 0.55, 95% confidence interval [0.43, 0.71], P < .001. Demographic, clinical, and lifestyle risk factors varied between women and men but did not account for this difference, which was limited to individuals without apolipoprotein E (APOE)‐ε4 alleles (interaction P = .034).ConclusionsAmong overweight and obese adults with type 2 diabetes mellitus, traditional risk factors did not account for the lower prevalence of cognitive impairment observed in women compared with men.
SCN5A mutations in 442 neonates and children: genotype–phenotype correlation and identification of higher-risk subgroups
Baruteau, Alban‐Elouen , Kyndt, Florence , Behr, Elijah R. , Vink, Arja S. , Lachaud, Matthias , Joong, Anna , Horie, Minoru , Crotti, Lia , Bos, J. Martijn , Stephenson, Elizabeth A. , Wong, Leonie C.H., Abrams, Dominic J. , Davis, Andrew M. , Winbo, Annika , Sanatani, Shubhayan , Liberman, Leonardo , Kaski, Juan Pablo , Rudic, Boris , Kwok, Sit Yee, Rieubland, Claudine, Tfelt‐Hansen, Jacob , Hare, George F. Van , Guyomarc’h-Delasalle, Béatrice, Wijeyeratne, Yanushi D. , Gourraud, Jean‐Baptiste , Marec, Hervé Le , Ozawa, Junichi , Fressart, Véronique , Lupoglazoff, Jean‐Marc, Spazzolini, Carla , Aiba, Takeshi , Tester, David J. , Zahavich, Laura , Beauséjour-Ladouceur, Virginie, Jadhav, Mangesh P. , Skinner, Jonathan R. , Franciosi, Sonia , Abdelsayed, Mena , Ruben, Peter C. , Yung, Tak‐Cheung , Ackerman, Michael J. , Wilde, Arthur A.M. , Probst, Vincent , Bos, Johan M, Crotti, Lia , Horie, Minoru , Behr, Elijah Raphael , Probst, Vincent , Bos, Johan M , Tfelt-Hansen, Jacob , Davis, Andrew , Skinner, Jonathan R , Sanatani, Shubhayan , Abrams, Dominic J , Baruteau, Alban-Elouen , Schott, Jean‐Jacques , Denjoy, Isabelle , Shimizu, Wataru , Dubin, Anne M. , Blom, Nico A. , Dagradi, Federica , Aiba, Takeshi , Krahn, Andrew D. , Schwartz, Peter J. , Kaski, Juan P , Gourraud, Jean-Baptiste , Spazzolini, Carla

Mayo Clinic

European Heart Journal | July 3, 2018 | Volume: 39 | Issue: 31 | Pages: 2879-2887

10.1093/eurheartj/ehy412 | PMID 30059973 Get It

Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study
Qian, Frank , Wang, Shengfeng , McGuffog, Lesley, Barrowdale, Daniel , Oosterwijk, Jan C., Evans, D. Gareth , Engel, Christoph , Kast, Karin, Aalfs, Cora M. , Adank, Muriel A. , Agnarsson, Bjarni A. , Aittomäki, Kristiina, Alducci, Elisa, Andrulis, Irene L. , Ausems, Margreet G.E.M. , Azzollini, Jacopo , Barouk-Simonet, Emmanuelle, Belotti, Muriel, Benı́tez, Javier , Berger, Andreas, Borg, Åke , Bradbury, Angela R. , Brunet, Joan , Caldés, Trinidad , Caputo, Sandrine M. , Chiquette, Jocelyne , Collée, J. Margriet, Coupier, Isabelle, Daly, Mary B., Davidson, Rosemarie, Donaldson, Alan, Dorfling, Cecilia M., Eeles, Rosalind A. , Feliubadaló, Lídia , Foretová, Lenka , Fowler, Jeffrey M., Friedman, Eitan , Frost, Debra, Ganz, Patricia A. , García‐Barberán, Vanesa , Glendon, Gord , Gómez, E. , Hahnen, Eric , Hamann, Ute, Henderson, Alex, Hendricks, Carolyn B., Hulick, Peter J. , Imyanitov, Evgeny N., Izatt, Louise , Jakubowska, Anna , Kaczmarek, Katarzyna, Kang, Eunyoung , Kets, Carolien M., Kim, Sung-Won, Kwong, Ava , Laitman, Yael , Lasset, Christine, Lee, Min Hyuk , Lee, Jong Won, Lee, Jihyoun , Lester, Jenny, Lesueur, Fabienne , Loud, Jennifer T. , Mebirouk, Noura, Meijers‐Heijboer, Hanne , Meindl, Alfons , Montagna, Marco , Mooij, Thea M. , Mouret‐Fourme, Emmanuelle, Nathanson, Katherine L. , Niederacher, Dieter , Offit, Kenneth, Oláh, Edith , Ong, Kai-Ren, Ottini, Laura , Park, Sue K. , Peterlongo, Paolo , Pfeiler, Georg , Phelan, Catherine M., Poppe, Bruce , Pradhan, Nisha , Radice, Paolo , Ramus, Susan J. , Rantala, Johanna, Rodriguez, Gustavo C. , Schmutzler, Rita K., Selkirk, Christina G. , Shah, Payal D. , Simard, Jacques , Sutter, Christian , Tan, Yen Y. , Teixeira, R , Teo, Soo‐Hwang , Terry, Mary Beth , Thomassen, Mads , Toland, Amanda Ewart, Tucker, Kathy , Engelen, Klaartje van , Rensburg, Elizabeth J. van , Wang‐Gohrke, Shan , Wappenschmidt, Barbara , Weitzel, Jeffrey N. , Collaborators, GEMO Study, HEBON, EMBRACE, Greene, Mark H. , Rookus, Matti A. , Easton, Douglas F. , Chenevix‐Trench, Georgia , Antoniou, Antonis C. , Goldgar, David E., Olopade, Olufunmilayo I. , Huo, Dezheng , Durocher, Francine , Teixeira, Manuel R. , Mitchell, Jonathan A. , Białkowska, Katarzyna , Hulick, Peter J , Lesueur, Fabienne , Peterlongo, Paolo , Ramus, Susan J , Teixeira, Manuel R , Teo, Soo H , van Rensburg, Elizabeth J , Radice, Paolo , Weitzel, Jeffrey N , Azzollini, Jacopo , Brunet, Joan , Eeles, Rosalind A , Evans, D Gareth , Olopade, Olufunmilayo I , Jakubowska, Anna , Nathanson, Katherine L , Barrowdale, Daniel , Benitez, Javier , Engel, Christoph , Montagna, Marco , Simard, Jacques , Chenevix-Trench, Georgia , Ottini, Laura , Mitchell, Jonathan S. , Leslie, Goska , Chung, Wendy K. , Adlard, Julian , Arun, Banu , Barwell, Julian , Borg, Åke , Buys, Saundra S. , Caligo, Maria A. , Campbell, Ian , Claes, Kathleen , Couch, Fergus J. , Dı́ez, Orland , Domchek, Susan M. , Garber, Judy E. , Godwin, Andrew K. , Gronwald, Jacek , Hopper, John L. , Isaacs, Claudine , Izquierdo, Á. , Karlan, Beth Y. , Kim, Sung-Won , Lasset, Christine , Lubiński, Jan , Meindl, Alfons , Miller, Austin , Morrison, Patrick J. , Neuhausen, Susan L. , Nevanlinna, Heli , Nielsen, Finn Cilius , Nussbaum, Robert L. , Robson, Mark E. , Singer, Christian F. , Giles, Graham G , Stoppa‐Lyonnet, Dominique , Tischkowitz, Marc D. , Toland, Amanda Ewart , Tung, Nadine , Asperen, Christi J. van , Yannoukakos, Drakoulis , Collaborators, GEMO Study, HEBON, EMBRACE, Rebbeck, Timothy R. , Feliubadaló, Lidia , Gómez-García, Encarna B , Terry, Mary Beth , Kwong, Ava

Mayo Clinic

JNCI: Journal of the National Cancer Institute | July 3, 2018 | Volume: 111 | Issue: 4 | Pages: 350-364

10.1093/jnci/djy132 | PMID 30312457 Get It

Epithelial‐to‐mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity
Hong, Deli , Fritz, Andrew J. , Zaidi, Sayyed K. , Wijnen, André J. van , Nickerson, Jeffrey A. , Imbalzano, Anthony N. , Lian, Jane B. , Stein, Janet L. , Stein, Gary S. , van Wijnen, Andre J , Stein, Gary S

Mayo Clinic

Journal of Cellular Physiology | July 3, 2018 | Volume: 233 | Issue: 12 | Pages: 9136-9144

10.1002/jcp.26847 | PMID 29968906 Get It

Breast cancer is the most common cancer in women, and accounts for ~30% of new cancer cases and 15% of cancer‐related deaths. Tumor relapse and metastasis are primary factors contributing to breast cancer‐related deaths. Therefore, the challenge for breast cancer treatment is to sustain remission. A driving force behind tumor relapse is breast cancer heterogeneity (both intertumor, between different patients, and intratumor, within the same tumor). Understanding breast cancer heterogeneity is necessary to develop preventive interventions and targeted therapies. A recently emerging concept is that intratumor heterogeneity is driven by cancer stem cells (CSCs) that are capable of giving rise to a multitude of different cells within a tumor. Studies have highlighted linkage of CSC formation with epithelial‐to‐mesenchymal transition (EMT). In this review, we summarize the current understanding of breast cancer heterogeneity, links between EMT and CSCs, regulation of EMT by Runx transcription factors, and potential therapeutic strategies targeting these processes.
Perioperative Medication Management: Reconciling Differences across Clinical Sites
Duncan, Benjamin J. , Furniss, Stephanie K, Solomon, Andrew , Burton, Matthew M., Poterack, Karl A. , Miksch, Timothy, Helmers, Richard A. , Zheng, Lu , Doebbeling, Bradley N. , Grando, Adela , Kaufman, David Ross

Mayo Clinic

Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care | June 29, 2018 | Volume: 7 | Issue: 1 | Pages: 44-51

10.1177/2327857918071010 Get It

Medication reconciliation (MedRec) is a mission-critical process which can serve to reduce adverse drug events (ADEs) in surgical settings. However, providing quality care is limited by current health information technology (IT), which is often inefficient and unintuitive due to poor usability, resulting in high cognitive burden. We have been characterizing EHR mediated workflow in the Mayo Clinic enterprise prior to a system-wide electronic health records (EHR) conversion in order to harmonize workflows. We compared and evaluated MedRec processes in pre-operative nursing assessments across two different EHRs in place in different locales at baseline. The interfaces differed both in their modes of interaction and cognitive support. Analyses surfaced interface elements that were unintuitive and inefficient, creating unnecessary complexities in clinicians’ interactive behavior. Keystroke level models (KLM), a modeling tool for predicting task completion time, showed that to access medication lists required a different series of operations across the two systems. Different designs can differentially mediate task performance, which can aid in the mitigation of errors for complex cognitive tasks. Identification of barriers in EHR-mediated workflow and barriers to interface usability could lead to system redesigns that minimize cognitive load while improving patient safety and efficiency.
Increasing Evidence-Based Interventions in Patients with Acute Infections in a Resource-Limited Setting: A Before-and-After Feasibility Trial in Gitwe, Rwanda
Urayeneza, Olivier, Mujyarugamba, Pierre , Rukemba, Zacharie, Nyiringabo, Vincent, Ntihinyurwa, Polyphile , Baelani, John I., Kwizera, Arthur , Bagenda, Danstan , Mer, Mervyn , Musa, Ndidiamaka, Hoffman, Julia T., Mudgapalli, Ashok, Porter, Austin M., Kissoon, Niranjan , Ulmer, Hanno , Harmon, Lori, Farmer, Joseph C. , Dünser, Martin W. , Patterson, Andrew J.

Mayo Clinic

Critical Care Medicine | June 28, 2018 | Volume: 46 | Issue: 8 | Pages: 1357-1366

10.1097/ccm.0000000000003227 | PMID 29957715 Get It

Objective: To evaluate whether a focused education program and implementation of a treatment bundle increases the rate of early evidence-based interventions in patients with acute infections. Design: Single-center, prospective, before-and-after feasibility trial. Setting: Emergency department of a sub-Saharan African district hospital. Patients: Patients > 28 days of life admitted to the study hospital for an acute infection. Interventions: The trial had three phases (each of four months). Interventions took place during the second (educational program followed by implementation of the treatment bundle) and third (provision of resources to implement treatment bundle) phases. Measurements and Main Results: Demographic, clinical, and laboratory data were collected at study enrollment; 24, 48, and 72 hours after hospital admission; and at discharge. A total of 1,594 patients were enrolled (pre-intervention, n = 661; intervention I, n = 531; intervention II, n = 402). The rate of early evidence-based interventions per patient during Intervention Phase I was greater than during the pre-intervention phase (74 ± 17 vs. 79 ± 15%, p < 0.001). No difference was detected when data were compared between Intervention Phases I and II (79 ± 15 vs. 80 ± 15%, p = 0.58). No differences in the incidence of blood transfusion (pre-intervention, 6%; intervention I, 7%; intervention II, 7%) or severe adverse events in the first 24 hours (allergic reactions: pre-intervention, 0.2%; intervention I, 0%; intervention II, 0%; respiratory failure: pre-intervention, 2%; intervention I, 2%; intervention II, 2%; acute renal failure: pre-intervention, 2%; intervention I, 2%; intervention II, 1%) were observed. Conclusions: Our results indicate that a focused education program and implementation of an infection treatment bundle in clinical practice increased the rate of early evidence-based interventions in patients with acute infections (mostly malaria) admitted to a sub-Saharan African district hospital. Provision of material resources did not further increase this rate. While no safety issues were detected, this could be related to the very low disease severity of the enrolled patient population (www.clinicaltrials.gov: NCT02697513).
AHNS Series: Do you know your guidelines? AHNS Endocrine Section Consensus Statement: State‐of‐the‐art thyroid surgical recommendations in the era of noninvasive follicular thyroid neoplasm with papillary‐like nuclear features
Nikiforov, Yuri E. , Terris, Davis, Seethala, Raja R. , Sabra, Mona M. , McIver, Bryan, Bernet, Victor , Harrell, R. Mack, Busaidy, Naifa L. , Sadow, Peter M. , Shindo, Maisie L., Nikiforov, Yuri , Terris, Davis , Bernet, Victor J, Ferris, Robert L. , Ridge, John Andrew , Angelos, Peter , Duh, Quan‐Yang , Wong, Richard J. , Fagin, James A. , Cibas, Edmund S. , Faquin, William C , Baloch, Zubair , Orloff, Lisa A. , Davies, Louise , Randolph, Gregory William

Mayo Clinic

Head & Neck | June 27, 2018 | Volume: 40 | Issue: 9 | Pages: 1881-1888

10.1002/hed.25141 | PMID 29947030 Get It

AbstractThe newly introduced pathologic diagnosis of noninvasive follicular thyroid neoplasm with papillary‐like nuclear features (NIFTP) will result in less bilateral thyroid surgery as well as deescalation in T4 suppressive and radioactive iodine treatment. Although, NIFTP is a nonmalignant lesion that has nuclear features of some papillary malignancies, the challenge for the surgeon is to identify a lesion as possibly NIFTP before the pathologic diagnosis. NIFTP, due to its reduction of overall rates of malignancy, will result in the initial surgical pendulum swinging toward lobectomy instead of initial total thyroidectomy. This American Head and Neck Society endocrine section consensus statement is intended to inform preoperative evaluation to attempt to identify those patients whose final pathology report may ultimately harbor NIFTP and can be offered a conservative surgical plan to assist in cost‐effective, optimal management of patients with NIFTP.
Reply to E.L. Pollom et al, N. Ohri et al, A. Fiorentino et al, D.R. Wahl et al, N. Kim et al, J. Boda-Heggemann et al, S. Rana et al, N. Sanuki et al, J.R. Olsen et al, G.L. Smith et al, and A. Shinde et al
Rajyaguru, Devalkumar J., Borgert, Andrew J. , Hálfdánarson, Þorvarður R. , Truty, Mark J. , Kurup, A. Nicholas , Halfdanarson, Thorvardur R , Go, Ronald S.

Mayo Clinic

Journal of Clinical Oncology | June 27, 2018 | Volume: 36 | Issue: 24 | Pages: 2567-2569

10.1200/jco.2018.78.6418 | PMID 29945519 Get It